Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Parent de Curzon

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annales Pharmaceutiques Francaises|March 26, 2026
Virginie Siorat, Marion Tano, Olivier Parent de Curzon, et al.
Pharmacoeconomics|March 27, 2013
Temporary authorization for use: does the French patient access programme for unlicensed medicines impact market access after formal licensing?Albane Degrassat-Théas, Pascal Paubel, Olivier Parent de Curzon, et al.
Journal of Comparative Effectiveness Research|March 15, 2018
Economic and organizational impact of the changing hospital funding practices of erythropoiesis-stimulating agents on the management of care of dialysis patients in FranceCarole Therasse, Isabelle Fusier, Anne-Laure Cordonnier, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annales Pharmaceutiques Francaises|March 26, 2026
Virginie Siorat, Marion Tano, Olivier Parent de Curzon, et al.
Pharmacoeconomics|March 27, 2013
Temporary authorization for use: does the French patient access programme for unlicensed medicines impact market access after formal licensing?Albane Degrassat-Théas, Pascal Paubel, Olivier Parent de Curzon, et al.
Journal of Comparative Effectiveness Research|March 15, 2018
Economic and organizational impact of the changing hospital funding practices of erythropoiesis-stimulating agents on the management of care of dialysis patients in FranceCarole Therasse, Isabelle Fusier, Anne-Laure Cordonnier, et al.
Pageof 1